Overview Fundamentals API Earnings EOD API Sample Code Pricing

Cytogen Inc (217330 KQ) stock market data APIs

₩7280 340(4.9%) as of November 25, 2024
Price chart is built with Anychart

Cytogen, Inc., a biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea. The company offers cell isolators that enrich CTCs from human blood and/or body fluid using high density microporous chips; IF stainers, automated immunofluorescent staining system; and cell image analyzers, which help captures immunofluorescent images of cells stained with anti-EpCAM, -CD45, and CK antibodies. The company sells its products under the Smart Biopsy brand name. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea.

Cytogen Inc Financial Data Overview

6940
7280
-
7380
6930
6370-16640
165 034 M
23 050 K
3 554 M
-132.1246
0.244
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '217330',
Type: 'Common Stock',
Name: 'Cytogen Inc',
Exchange: 'KQ',
CurrencyCode: 'KRW',
CurrencyName: 'Korean Won',
CurrencySymbol: '₩',
CountryName: 'Korea',
CountryISO: 'KR',
OpenFigi: 'BBG00M8WDQ55',
ISIN: 'KR7217330000',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
}

Cytogen Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 554 M
  • EBITDA -10 759 536 640
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Cytogen Inc Earnings via APIs

  • Latest Release 2024-06-30
  • EPS/Forecast NaN

Get Cytogen Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com